Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03955471
Title Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer (MOONSTONE)
Recruitment Suspended
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

ovarian clear cell carcinoma

ovarian serous carcinoma

endometrioid ovary carcinoma

fallopian tube cancer

peritoneum cancer

Therapies

Dostarlimab + Niraparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.